Yayıncı "Lippincott Williams & Wilkins" Bildiri Koleksiyonu için listeleme
Toplam kayıt 20, listelenen: 1-20
-
Allyl isothiocyanate enhances brain neuronal plasticity proteins via inhibition of inflammation proteins
(Lippincott Williams & Wilkins, 2018)… -
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
(Lippincott Williams & Wilkins, 2021)Background: In the current study, we evaluated whether the response first-line chemotherapy could impact atezolizumab benefit in terms of response rate and overall survival in patients with metastatic urothelial carcinoma. ... -
Clinical assessment of HRD scoring in relation to PARPi response in terms of statistical guidance on reporting results for CDx tests evaluation.
(Lippincott Williams & Wilkins, 2023)... -
Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.
(Lippincott Williams & Wilkins, 2023)... -
Intrahepatic cholangiocarcinoma in patients undergoing liver transplantation for hepatocellular carcinoma
(Lippincott Williams & Wilkins, 2018)… -
Is body mass index as a predictor of hepatic steatosis in living liver donors?
(Lippincott Williams & Wilkins, 2018)… -
Is routine reconstruction for all sizeable anterior sector drainage veins necessary in right lobe living donor liver transplantation?
(Lippincott Williams & Wilkins, 2019)--- -
KEYFORM-008: Coformulated favezelimab and pembrolizumab (MK4280A) versus chemotherapy in relapsed/refractory classical Hodgkin lymphoma.
(Lippincott Williams & Wilkins, 2023)... -
The knowledges and opinions of ICU professionals about brain death and organ donation
(Lippincott Williams & Wilkins, 2017)... -
Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice
(Lippincott Williams & Wilkins, 2022)Background: Anti-tumor activity and manageable safety profile of immune checkpoint blockade therapies (ICT) have been demonstrated in previous clinical trials in patients with metastatic urothelial carcinoma. To the best ... -
Outcomes following deceased and live donor liver transplantation for the indication of acute liver failure: A multicenter experience
(Lippincott Williams & Wilkins, 2021)... -
Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer
(Lippincott Williams & Wilkins, 2021)Background: Efficacy of anti-angiogenic and anti-EGFR agents has been demonstrated metastatic colorectal cancer (mCRC). Real-world evidence is especially important to detect the findings of patients outside of clinical ... -
The relationship between the change with neoadjuvant chemotherapy in the tumor-infiltrating lymphocyte (TIL) expressions and pathological response in breast cancer patients.
(Lippincott Williams & Wilkins, 2023)... -
Segmental epidural anaesthesia for percutaneus kyphoplasty
(Lippincott Williams & Wilkins, 2014)… -
Surgical, pathological and clinical features of advanced collorectal cancers with metastasectomy. "Onco-Colon Turkey Registry" real-life data
(Lippincott Williams & Wilkins, 2022)Background: The contribution of metastasectomy to progression-free survival (PFS) and overall survival (OS) in patients (pts) with advanced stage colorectal cancer has been demonstrated in clinical trials. However, clinical ...